InterventionsReview

Advances in weight-loss-independent cardiovascular protective mechanisms of GLP-1 receptor agonists

Graphical abstract from Peptides — Graphical abstractMa et al.

Peptides

The paper

Ma J, Feng X, Xu W et al.

Peptides · 23 Sep 2026

doi.org/10.1016/j.peptides.2026.171519 PubMed 42778024

Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Neurology Genetics · 4 Oct 2026